Cells, boundaries, and the emergence of biological order
Peer-Reviewed Publication
Updates every hour. Last Updated: 25-Oct-2026 00:17 ET (25-Oct-2026 04:17 GMT/UTC)
During embryonic development, cells with biochemically distinct ends – called polarised cells – organise into distinct patterns based on their orientation. Using theoretical physics approaches and quantitative experiments, scientists have shown how the shape of tissue boundaries determines these patterns. They found that specific features in these patterns – called topological defects – determine where the proamniotic cavity, an important structure for embryonic development, forms. This research identifies fundamental principles that govern how order and functional structures emerge inside complex biological systems.
Cricket mothers transmit environmental information that determines embryonic developmental timing. Researchers have demonstrated that entry into developmental arrest is controlled by an integrated program of transcriptional, epigenetic, and metabolic reprogramming. Their study uncovers a system-level mechanism linking environmental cues to embryonic fate.
Actinobacteria TFDB is an integrated database for Actinobacteria transcription factors (TFs). The platform provides a one-stop resource for analyzing TF characteristics, target genes, ligands, and posttranslational modifications to advance microbiology and synthetic biology research.
Researchers have developed a programmable genome evolution platform called RAMPAGE that rapidly generates beneficial mutations in the industrial yeast Pichia pastoris. The technology enabled the evolution of strains that tolerate extremely high methanol concentrations, grow at elevated temperatures, and overcome growth defects caused by glycoengineering. The platform could accelerate the development of more robust microbial cell factories for sustainable biomanufacturing.
The discovery of Planigale petrophila, named after the rocky landscapes in Arnhem Land, where it was found, was published in the Zoological Journal of the Linnean Society.
Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of death worldwide. Elevated low-density lipoprotein cholesterol (LDL-C) is a major modifiable driver of ASCVD, and PCSK9 has become an important therapeutic target because it regulates hepatic LDL receptor recycling and circulating LDL-C levels. Although PCSK9-targeting monoclonal antibodies and siRNA therapies can substantially lower LDL-C, their cost and need for repeated administration have motivated efforts to develop longer-lasting and more accessible approaches.